Effectiveness of tranexamic acid on blood loss in patients undergoing elective cesarean section: randomized clinical trial. (åpner nytt vindu)

Abdel-Aleem H, Alhusaini TK, Abdel-Aleem MA, Menoufy M, Gülmezoglu AM.

Kilde‎: J Matern Fetal Neonatal Med 2013;26(17):1705-9.

Arkiv‎: PubMed 23574458

https://www.ncbi.nlm.nih.gov/pubmed/23574458 (åpner nytt vindu)

Effect of treatment delay on the effectiveness and safety of antifibrinolytics in acute severe haemorrhage: a meta-analysis of individual patient-level data from 40 138 bleeding patients. (åpner nytt vindu)

Gayet-Ageron A, Prieto-Merino D, Ker K, Shakur H, Ageron FX, Roberts I; Antifibrinolytic Trials Collaboration

Kilde‎: Lancet 2018;391(10116):125-32.

Arkiv‎: PubMed 29126600

DOI‎: 10.1016/S0140-6736(17)32455-8

https://www.ncbi.nlm.nih.gov/pubmed/29126600 (åpner nytt vindu)

Can intravenous injection of tranexamic acid be used in routine practice with active management of the third stage of labor in vaginal delivery? A randomized controlled study. (åpner nytt vindu)

Gungorduk K, Asıcıoğlu O, Yıldırım G, Ark C, Tekirdağ Aİ, Besımoglu B.

Kilde‎: Am J Perinatol 2013;30(5):407-13.

Arkiv‎: PubMed 23023559

DOI‎: 10.1055/s-0032-1326986

https://www.ncbi.nlm.nih.gov/pubmed/23023559 (åpner nytt vindu)

Efficacy of intravenous tranexamic acid in reducing blood loss after elective cesarean section: a prospective, randomized, double-blind, placebo-controlled study. (åpner nytt vindu)

Gungorduk K, Yıldırım G, Asıcıoğlu O, Gungorduk OC, Sudolmus S, Ark C.

Kilde‎: Am J Perinatol 2011;28(3):233-40.

Arkiv‎: PubMed 20979013

https://www.ncbi.nlm.nih.gov/pubmed/20979013 (åpner nytt vindu)

Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial. (åpner nytt vindu)

Shakur S, Roberts I, Fawole B, Chaudhri R, El-Sheikh M, et al.; WOMAN Trial Collaborators

Kilde‎: Lancet 2017;389(10084):2105-16.

Arkiv‎: PubMed 28456509

DOI‎: 10.1016/S0140-6736(17)30638-4

https://www.ncbi.nlm.nih.gov/pubmed/28456509 (åpner nytt vindu)

Tranexamic acid for preventing postpartum blood loss after cesarean delivery: a systematic review and meta-analysis of randomized controlled trials. (åpner nytt vindu)

Simonazzi G, Bisulli M, Saccone G, Moro E, Marshall A, Berghella V.

Kilde‎: Acta Obstet Gynecol Scand 2016;95(1):28-37.

Arkiv‎: PubMed 26698831

DOI‎: 10.1111/aogs.12798

https://www.ncbi.nlm.nih.gov/pubmed/26698831 (åpner nytt vindu)

Randomized controlled trial of tranexamic acid among parturients at increased risk for postpartum hemorrhage undergoing cesarean delivery. (åpner nytt vindu)

Sujata N, Tobin R, Kaur R, Aneja A, Khanna M, Hanjoora VM.

Kilde‎: Int J Gynaecol Obstet 2016;133(3):312-5.

Arkiv‎: PubMed 26952346

DOI‎: 10.1016/j.ijgo.2015.09.032

https://www.ncbi.nlm.nih.gov/pubmed/26952346 (åpner nytt vindu)

Use of recombinant activated factor VII in primary postpartum hemorrhage: the Northern European registry 2000-2004. (åpner nytt vindu)

Alfirevic Z, Elbourne D, Pavord S, Bolte A, Van Geijn H, Mercier F, Ahonen J, Bremme K, Bødker B, Magnúsdóttir EM, Salvesen K, Prendiville W, Truesdale A, Clemens F, Piercy D, Gyte G.

Kilde‎: Obstet Gynecol 2007;110(6):1270-8.

Arkiv‎: PubMed 18055720

DOI‎: 10.1097/01.AOG.0000288515.48066.99

https://www.ncbi.nlm.nih.gov/pubmed/18055720 (åpner nytt vindu)

The use of recombinant activated FVII in postpartum hemorrhage. (åpner nytt vindu)

Franchini M, Franchi M, Bergamini V, Montagnana M, Salvagno GL, Targher G, Lippi G.

Kilde‎: Clin Obstet Gynecol 2010;53(1):219-27.

Arkiv‎: PubMed 20142658

DOI‎: 10.1097/GRF.0b013e3181cc4378

https://www.ncbi.nlm.nih.gov/pubmed/20142658 (åpner nytt vindu)

Recombinant human factor VIIa prevents hysterectomy in severe postpartum hemorrhage: single center study. (åpner nytt vindu)

Huber AW, Raio L, Alberio L, Ghezzi F, Surbek DV.

Kilde‎: J Perinat Med 2011;40(1):43-9.

Arkiv‎: PubMed 22017328

DOI‎: 10.1515/JPM.2011.109

https://www.ncbi.nlm.nih.gov/pubmed/22017328 (åpner nytt vindu)

Postpartum hemorrhage: when uterotonics and sutures fail. (åpner nytt vindu)

James AH, McLintock C, Lockhart E.

Kilde‎: Am J Hematol 2012;87 Suppl 1:S16-22.

Arkiv‎: PubMed 22430921

DOI‎: 10.1002/ajh.23156

https://www.ncbi.nlm.nih.gov/pubmed/22430921 (åpner nytt vindu)

Recombinant activated factor VII (rFVIIa/NovoSeven®) in the management of severe postpartum haemorrhage: initial report of a multicentre case series in Japan. (åpner nytt vindu)

Kobayashi T, Nakabayashi M, Yoshioka A, Maeda M, Ikenoue T.

Kilde‎: Int J Hematol 2012;95(1):57-63.

Arkiv‎: PubMed 22160834

DOI‎: 10.1007/s12185-011-0974-9

https://www.ncbi.nlm.nih.gov/pubmed/22160834 (åpner nytt vindu)

Recombinant human FVIIa for reducing the need for invasive second-line therapies in severe refractory postpartum hemorrhage: a multicenter, randomized, open controlled trial. (åpner nytt vindu)

Lavigne-Lissalde G, Aya AG, Mercier FJ, Roger-Christoph S, Chauleur C, Morau E, Ducloy-Bouthors AS, Mignon A, Raucoules M, Bongain A, Boehlen F, de Moerloose P, Bouvet S, Fabbro-Peray P, Gris JC.

Kilde‎: J Thromb Haemost 2015;13(4):520-9.

Arkiv‎: PubMed 25594352

DOI‎: 10.1111/jth.12844

https://www.ncbi.nlm.nih.gov/pubmed/25594352 (åpner nytt vindu)

Recombinant factor VIIa after amniotic fluid embolism and disseminated intravascular coagulopathy. (åpner nytt vindu)

Lim Y, Loo CC, Chia V, Fun W.

Kilde‎: Int J Gynaecol Obstet 2004;87(2):178-9.

Arkiv‎: PubMed 15491576

DOI‎: 10.1016/j.ijgo.2004.08.007

https://www.ncbi.nlm.nih.gov/pubmed/15491576 (åpner nytt vindu)

Successful treatment of severe intra-abdominal bleeding associated with disseminated intravascular coagulation using recombinant activated factor VII. (åpner nytt vindu)

Moscardó F, Pérez F, de la Rubia J, Balerdi B, Lorenzo JI, Senent ML, Aznar I, Carceller S, Sanz MA.

Kilde‎: Br J Haematol 2001;114(1):174-6.

Arkiv‎: PubMed 11472364

https://www.ncbi.nlm.nih.gov/pubmed/11472364 (åpner nytt vindu)

Successful management by recombinant activated factor VII in a case of disseminated intravascular coagulopathy caused by obstetric hemorrhage. (åpner nytt vindu)

Nohira T, Osakabe Y, Suda S, Takahashi C, Tanaka A, Ikeda K, Ikeda T, Okabe K.

Kilde‎: J Obstet Gynaecol Res 2008;34(4 Pt 2):623-30.

Arkiv‎: PubMed 18840167

https://www.ncbi.nlm.nih.gov/pubmed/18840167 (åpner nytt vindu)

Recombinant factor VIIa as last-resort treatment of desperate haemorrhage. (åpner nytt vindu)

Palmason R, Vidarsson B, Sigvaldason K, Ingimarsson JP, Gudbjartsson T, Sigurdsson GH, Onundarson PT.

Kilde‎: Acta Anaesthesiol Scand 2012;56(5):636-44.

Arkiv‎: PubMed 22489992

DOI‎: 10.1111/j.1399-6576.2012.02688.x

https://www.ncbi.nlm.nih.gov/pubmed/22489992 (åpner nytt vindu)

Factor VIIa in puerperal hemorrhage with disseminated intravascular coagulation. (åpner nytt vindu)

Pepas LP, Arif-Adib M, Kadir RA.

Kilde‎: Obstet Gynecol 2006;108(3 Pt 2):757-61.

Arkiv‎: PubMed 17018493

DOI‎: 10.1097/01.AOG.0000197064.44340.d4

https://www.ncbi.nlm.nih.gov/pubmed/17018493 (åpner nytt vindu)

Recombinant activated factor VII in obstetric hemorrhage: experiences from the Australian and New Zealand Haemostasis Registry. (åpner nytt vindu)

Phillips LE, McLintock C, Pollock W, Gatt S, Popham P, Jankelowitz G, Ogle R, Cameron PA; Australian and New Zealand Haemostasis Registry.

Kilde‎: Anesth Analg 2009;109(6):1908-15.

Arkiv‎: PubMed 19923520

DOI‎: 10.1213/ANE.0b013e3181c039e6

https://www.ncbi.nlm.nih.gov/pubmed/19923520 (åpner nytt vindu)

Recombinant factor VIIa to successfully manage disseminated intravascular coagulation from amniotic fluid embolism. (åpner nytt vindu)

Prosper SC, Goudge CS, Lupo VR.

Kilde‎: Obstet Gynecol 2007;109(2 Pt2):524-5.

Arkiv‎: PubMed 17267882

DOI‎: 10.1097/01.AOG.0000235711.11817.8c

https://www.ncbi.nlm.nih.gov/pubmed/17267882 (åpner nytt vindu)

The efficacy of fibrinogen concentrate compared with cryoprecipitate in major obstetric haemorrhage--an observational study. (åpner nytt vindu)

Ahmed S, Harrity C, Johnson S, Varadkar S, McMorrow S, Fanning R, Flynn CM, O'Riordan JM, Byrne BM.

Kilde‎: Transfus Med 2012;22(5):344-9.

Arkiv‎: PubMed 22994449

https://www.ncbi.nlm.nih.gov/pubmed/22994449 (åpner nytt vindu)

The use of fibrinogen concentrate to correct hypofibrinogenaemia rapidly during obstetric haemorrhage. (åpner nytt vindu)

Bell SF, Rayment R, Collins PW, Collis RE.

Kilde‎: Int J Obstet Anesth 2010;19(2):218-23.

Arkiv‎: PubMed 20194010

DOI‎: 10.1016/j.ijoa.2009.08.004

https://www.ncbi.nlm.nih.gov/pubmed/20194010 (åpner nytt vindu)

Association between fibrinogen level and severity of postpartum haemorrhage: secondary analysis of a prospective trial. (åpner nytt vindu)

Cortet M, Deneux-Tharaux C, Dupont C, Colin C, Rudigoz RC, Bouvier-Colle MH, Huissoud C.

Kilde‎: Br J Anaesth 2012;108(6):984-9.

Arkiv‎: PubMed 22490316

DOI‎: 10.1093/bja/aes096

https://www.ncbi.nlm.nih.gov/pubmed/22490316 (åpner nytt vindu)

Association between fibrinogen levels and severity of postpartum hemorrhage in singleton vaginal deliveries at a Japanese perinatal center. (åpner nytt vindu)

Shibata Y, Shigemi D, Ito M, Terada K, Nakanishi K, Kato M, Igarashi M, Suzuki S.

Kilde‎: J Nippon Med Sch 2014;81(2):94-6.

Arkiv‎: PubMed 24805095

https://www.ncbi.nlm.nih.gov/pubmed/24805095 (åpner nytt vindu)

A systematic review: the use of desmopressin for treatment and prophylaxis of bleeding disorders in pregnancy. (åpner nytt vindu)

Trigg DE, Stergiotou I, Peitsidis P, Kadir RA.

Kilde‎: Haemophilia 2012;18(1):25-33.

Arkiv‎: PubMed 21624012

DOI‎: 10.1111/j.1365-2516.2011.02573.x

https://www.ncbi.nlm.nih.gov/pubmed/21624012 (åpner nytt vindu)

Tisseel for management of traumatic postpartum haemorrhage. (åpner nytt vindu)

Dhulkotia JS, Alazzam M, Galimberti A.

Kilde‎: Arch Gynecol Obstet 2009;279(3):437-9.

Arkiv‎: PubMed 18985368

DOI‎: 10.1007/s00404-008-0824-z

https://www.ncbi.nlm.nih.gov/pubmed/18985368 (åpner nytt vindu)

Uterine packing with chitosan-covered tamponade to treat postpartum hemorrhage. (åpner nytt vindu)

Henrich W, Dückelmann A, Braun T, Hinkson L

Kilde‎: Am J Obstet Gynecol 2024;230(3S):S1061-65.

Arkiv‎: PubMed 38462249

DOI‎: 10.1016/j.ajog.2022.11.1297

https://pubmed.ncbi.nlm.nih.gov/38462249/ (åpner nytt vindu)

Use of FloSeal haemostatic gel in massive obstetric haemorrhage: a case report. (åpner nytt vindu)

Moriarty KT, Premila S, Bulmer PJ.

Kilde‎: BJOG 2008;115(6):793-5.

Arkiv‎: PubMed 18355369

DOI‎: 10.1111/j.1471-0528.2007.01654.x

https://www.ncbi.nlm.nih.gov/pubmed/18355369 (åpner nytt vindu)

Topical application of recombinant activated factor VII during cesarean delivery for placenta previa. (åpner nytt vindu)

Schjoldager BTBG, Mikkelsen E, Lykke MR, Præst J, Hvas AM, Heslet L, Secher NJ, Salvig JD, Uldbjerg N

Kilde‎: Am J Obstet Gynecol 2017;216(6):608.e1-5.

Arkiv‎: PubMed 28219621

DOI‎: 10.1016/j.ajog.2017.02.024

https://www.ncbi.nlm.nih.gov/pubmed/28219621 (åpner nytt vindu)

Fibrin sealant for management of complicated obstetric lacerations. (åpner nytt vindu)

Whiteside JL, Asif RB, Novello RJ.

Kilde‎: Obstet Gynecol 2010;115(2 Pt 2):403-4.

Arkiv‎: PubMed 20093858

DOI‎: 10.1097/AOG.0b013e3181bb1e28

https://www.ncbi.nlm.nih.gov/pubmed/20093858 (åpner nytt vindu)

Role of thromboelastography versus coagulation screen as a safety predictor in pre-eclampsia/eclampsia patients undergoing lower-segment caesarean section in regional anaesthesia. (åpner nytt vindu)

Ahmad A, Kohli M, Malik A, Kohli M, Bogra J, Abbas H, Gupta R, Kushwaha BB.

Kilde‎: J Obstet Gynaecol India 2016;66(Suppl 1):340-6.

Arkiv‎: PubMed 27651627

https://www.ncbi.nlm.nih.gov/pubmed/27651627 (åpner nytt vindu)

Assessment of coagulation in the obstetric population using ROTEM® thromboelastometry. (åpner nytt vindu)

Armstrong S, Fernando R, Ashpole K, Simons R, Columb M.

Kilde‎: Int J Obstet Anesth 2011;20(4):293-8.

Arkiv‎: PubMed 21835606

https://www.ncbi.nlm.nih.gov/pubmed/21835606 (åpner nytt vindu)

Obstetric hemorrhage and coagulation: an update. Thromboelastography, thromboelastometry, and conventional coagulation tests in the diagnosis and prediction of postpartum hemorrhage. (åpner nytt vindu)

de Lange NM, Lancé MD, de Groot R, Beckers EA, Henskens YM, Scheepers HC.

Kilde‎: Obstet Gynecol Surv 2012;67(7):426-35.

Arkiv‎: PubMed 22926249

DOI‎: 10.1097/OGX.0b013e3182605861

https://www.ncbi.nlm.nih.gov/pubmed/22926249 (åpner nytt vindu)

Major obstetric haemorrhage: monitoring with thromboelastography, laboratory analyses or both? (åpner nytt vindu)

Karlsson O, Jeppsson A, Hellgren M.

Kilde‎: Int J Obstet Anesth 2014;23(1):10-7.

Arkiv‎: PubMed 24342222

https://www.ncbi.nlm.nih.gov/pubmed/24342222 (åpner nytt vindu)

Fibrinogen as a therapeutic target for bleeding: a review of critical levels and replacement therapy. (åpner nytt vindu)

Levy JH, Welsby I, Goodnough LT.

Kilde‎: Transfusion 2014;54(5):1389-405.

Arkiv‎: PubMed 24117955

DOI‎: 10.1111/trf.12431

https://www.ncbi.nlm.nih.gov/pubmed/24117955 (åpner nytt vindu)

Coagulopathy and placental abruption: changing management with ROTEM-guided fibrinogen concentrate therapy. (åpner nytt vindu)

McNamara H, Mallaiah S, Barclay P, Chevannes C, Bhalla A.

Kilde‎: Int J Obstet Anesth 2015;24(2):174-9.

Arkiv‎: PubMed 25659517

https://www.ncbi.nlm.nih.gov/pubmed/25659517 (åpner nytt vindu)

Haemostatic monitoring during postpartum haemorrhage and implications for management. (åpner nytt vindu)

Solomon C, Collis RE, Collins PW.

Kilde‎: Br J Anaesth 2012;109(6):851-63.

Arkiv‎: PubMed 23075633

DOI‎: 10.1093/bja/aes361

https://www.ncbi.nlm.nih.gov/pubmed/23075633 (åpner nytt vindu)